| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $135.3M | -20.8% |
| SG&A Expense | $38.5M | -19.2% |
| Operating Income | -$183.8M | +15.9% |
| Interest Expense | $13.5M | -2.7% |
| Pre-tax Income | -$179.8M | +21.6% |
| Net Income | -$179.8M | +21.6% |
| EPS (Basic) | -$1.18 | +56.5% |
| EPS (Diluted) | -$1.18 | +56.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.1M | -71.3% |
| Short-term Investments | $264.3M | +83.9% |
| Current Assets | $306.5M | +17.0% |
| Total Assets | $311.9M | +14.5% |
| Current Liabilities | $51.6M | +4.8% |
| Long-term Debt | $814K | -93.2% |
| Total Liabilities | $249.1M | -4.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$159.2M | +14.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$111.0M | — |
| Financing Cash Flow | $190.2M | +62.4% |
| Free Cash Flow | -$159.2M | +15.1% |
| Stockholders' Equity |
| $62.8M |
| +419.7% |